Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Non-Current Liabilities (2019 - 2025)

Veracyte (VCYT) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $508000.0 as the latest value for Q2 2025.

  • Quarterly Other Non-Current Liabilities fell 76.91% to $508000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $508000.0 through Jun 2025, down 76.91% year-over-year, with the annual reading at $561000.0 for FY2024, 8.3% up from the prior year.
  • Other Non-Current Liabilities hit $508000.0 in Q2 2025 for Veracyte, down from $570000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $13.4 million in Q1 2024 to a low of $484000.0 in Q3 2023.
  • Historically, Other Non-Current Liabilities has averaged $2.7 million across 5 years, with a median of $1.6 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 246.37% in 2023 and later plummeted 95.76% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $5.7 million in 2021, then tumbled by 56.34% to $2.5 million in 2022, then tumbled by 79.26% to $518000.0 in 2023, then rose by 8.3% to $561000.0 in 2024, then fell by 9.45% to $508000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for VCYT at $508000.0 in Q2 2025, $570000.0 in Q1 2025, and $561000.0 in Q4 2024.